Asia

WuXi PharmaTech acquires two clinical research companies in China

Monday, October 24, 2011 11:44 AM

WuXi PharmaTech has acquired MedKey Med-Tech Development and Jiecheng Med-Tech Development, two related contract clinical research services companies based in Shanghai, China. The financial terms of the transaction were not disclosed.

More... »


ShangPharma acquires Charles River’s Shanghai facility

Monday, October 24, 2011 10:49 AM

ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, has acquired the assets in Charles River Laboratories International’s Shanghai research facility.

More... »


Astellas discontinues darexaban

Wednesday, September 28, 2011 01:47 PM

Astellas Pharma has decided to discontinue the global development of darexaban maleate, an oral direct Factor Xa inhibitor for all indications.

More... »

AstraZenca seeks partners in China

Friday, September 23, 2011 02:28 PM

AstraZeneca will continue its cooperation model on research and development (R&D) in China instead of merger and acquisition (M&A), the company's executive said, according to China Daily.

More... »

START expands with phase I center in Shanghai

Thursday, September 22, 2011 10:45 AM

South Texas Accelerated Research Therapeutics (START), a US-based group that claims to run the world’s largest co-ordinated network of phase I clinical trials in oncology, has opened a phase I research facility in China at Fudan University Shanghai Cancer Centre, the city’s largest cancer hospital, according to PharmaTimes.

More... »

OpenClinica, Athena partner to provide clinical trial support in China

Thursday, August 25, 2011 01:25 PM

OpenClinica has entered into a strategic alliance with Athena Healthcare Consultancy to bring the OpenClinica clinical trials software to the Chinese market. Headquartered in Shanghai, Athena will be the exclusive distributor of the OpenClinica enterprise edition and provide localized support and services for contract research organizations, pharmaceutical companies, and scientific institutes operating in China, according to Digital Journal.

More... »

StudyManager Evolve continues to expand in Chinese market

Friday, August 19, 2011 10:20 AM

StudyManager, a leading provider of integrated clinical trial management software (CTMS) and electronic data capture (EDC) solutions, has reported that GCP ClinPlus, a clinical research organization (CRO) in China, and Chongqing Jiachen Biotechnology have deployed StudyManager’s Evolve software to manage their latest clinical studies.

More... »

Report: clinical teams outsourcing in Asia now focusing on smaller markets

Thursday, July 21, 2011 12:44 PM

A new report says clinical development teams looking for outsourcing opportunities in Asia are turning their attention to smaller emerging markets rather than automatically plumping for established territories such as India and China, according to Pharma-Times.

More... »

China to spend billions on biotech development

Tuesday, July 5, 2011 12:27 PM

China will spend $308.5 billion on science and technology, making biotechnology a major priority in the next five years, said Chinese State Councilor Liu Yandong, according to China Daily

More... »

Singapore R&D consortium aims to tap into outsourcing trend

Tuesday, June 28, 2011 02:32 PM

Government agency International Enterprise (IE) Singapore has launched a biomedical R&D consortium involving seven companies based in the island state, with the aim of tapping into the trend for outsourcing of R&D across Asia, according to PharmaTimes.

More... »

`

CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs